Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

36.70 USD -0.05 (-0.14%)
Official Closing Price Updated: 7:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
From GlobeNewswire News Releases
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 17... 
From Business Wire News Releases
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the New England Journal of Medicine has published safety and final efficacy results from the pivotal Phase 3 trial of... 
From Business Wire News Releases
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
From GlobeNewswire News Releases
Thinking about buying stock in Pfizer, Rewalk Robotics, Veru, Arbutus Biopharma, or Plug Power?
InvestorsObserver issues critical PriceWatch Alerts for PFE, RWLK, VERU, ABUS, and PLUG. 
From PR Newswire
Thinking about buying stock in Pfizer, Ampio Pharmaceuticals, Aerpio Pharmaceuticals, Electrameccanica Vehicles, or United Airlines?
InvestorsObserver issues critical PriceWatch Alerts for PFE, AMPE, ARPO, SOLO, and UAL. 
From PR Newswire
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
Financialnewsmedia.com News Commentary 
From PR Newswire
U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age and Older
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a Biologics License Application (BLA) for its 20-valent pneumococcal conjugate... 
From Business Wire News Releases
Thinking about buying stock in Pfizer, Nio, Lexicon Pharmaceuticals, Oncolytics Biotech, or Boeing?
InvestorsObserver issues critical PriceWatch Alerts for PFE, NIO, LXRX, ONCY, and BA. 
From PR Newswire
Health Crisis-Induced Post-Traumatic Stress Disorder Creates Growing Need for Treatment Options
- FN Media Group Presents Microsmallcap.com Market Commentary 
From PR Newswire
Health Crisis-Induced Post-Traumatic Stress Disorder Creates Growing Need for Treatment Options
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today announced a strategic partnership with Pfizer Inc. (NYSE: PFE) with the goal of... 
From PR Newswire
Broad Diagnostic Measures Remain Crucial as Vaccinations Near
FinancialBuzz.com News Commentary 
From PR Newswire
Anti-Fibrinolytic Drugs Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2021-2026 | ExpertMarketResearch.com
Tags Reportedtimes iCN Internal Distribution English
From iCrowdNewswire
Thinking about buying stock in Pfizer, Moderna, Oncternal Therapeutics, Fate Therapeutics, or Atara Biotherapeutics?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, ONCT, FATE, and ATRA. 
From PR Newswire
Pfizer Reports Positive Clinical Data for BCMA-CD3 Bispecific Antibody (PF-06863135) in Multiple Myeloma
Pfizer Inc. (NYSE:PFE) today announced safety and clinical response results from the ongoing Phase 1 study (NCT03269136) for PF-06863135, an investigational B-cell maturation antigen (BCMA)... 
From Business Wire News Releases
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy
Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec... 
From Business Wire News Releases
Thinking about trading options or stock in Norwegian Cruise Line, Pfizer, General Electric, Walt Disney, or Intel Corp?
InvestorsObserver issues critical PriceWatch Alerts for NCLH, PFE, GE, DIS, and INTC. 
From PR Newswire
InvestorNewsBreaks – A Glimpse into Robinhood’s 100 Most Popular Stocks
From InvestorBrandNetwork
Transgene to Present Phase 1b/2 Trial Results of TG4001 in Combination with avelumab in Advanced HPV-Positive Cancers at ESMO IO 2020
Regulatory News: 
From Business Wire News Releases
Thinking about buying stock in Pfizer, China Automotive Systems, Omeros Corp, Nio, or FuelCell Energy?
InvestorsObserver issues critical PriceWatch Alerts for PFE, CAAS, OMER, NIO, and FCEL. 
From PR Newswire
Valneva Announces Acceleration of Pediatric Development for Lyme Disease Vaccine Candidate
From GlobeNewswire News Releases
A New Surge in Cases Emphasizes the Need for Effective Diagnostics
- FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in Aurora Cannabis, Pfizer, Viveve Medical, NetApp, or iBio?
InvestorsObserver issues critical PriceWatch Alerts for ACB, PFE, VIVE, NTAP, and IBIO. 
From PR Newswire
Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19
From GlobeNewswire News Releases
Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency... 
From Business Wire News Releases
Thinking about trading options or stock in Pfizer, Nio, Exxon Mobil, Roku, or Shopify?
InvestorsObserver issues critical PriceWatch Alerts for PFE, NIO, XOM, ROKU, and SHOP. 
From PR Newswire
ViiV Healthcare and Shutterstock Studios unite to tackle outdated perceptions of HIV with 'HIV in View'--a first-of-its-kind online HIV photography gallery
ViiV Healthcare and Shutterstock Studios today announced the launch of a new online photo gallery 'HIV in View', produced by Shutterstock in collaboration with ViiV Healthcare. The collection, curated... 
From PR Newswire
Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.